Clinical Trial: Repeated CBD Administration and Cannabis Outcomes

U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07434895) titled 'Repeated CBD Administration and Cannabis Outcomes' on Feb. 19.

Brief Summary: This outpatient study examines how cannabidiol (CBD) affects the behavioral and pain-relieving effects of cannabis.

Study Start Date: March, 2026

Study Type: INTERVENTIONAL

Condition: Cannabis Abuse Liability Experimental Pain in Healthy Human Participants

Intervention: DRUG: Cannabidiol, Medium Dose

Active Cannabidiol: Active cannabidiol (medium dose) will be administered orally for 14 days.

DRUG: Cannabidiol, Higher Dose

Description: Active Cannabidiol: Active cannabidiol (higher dose) will be administered orally for 14 days.

DRUG: Active Inhal...